Long-term Safety and Efficacy Profile of ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis
Clinical trial NCT05177835 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05177835
- Sponsor
- Abivax S.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-03
- Primary completion
- 2028-03-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.